Medicamen Biotech fundamental analysis
MEDICAMEQ
390.25
9.95 (-2.49%)Last updated on 9 Jan, 2026 | 15:31 IST
BUYSELL
The current prices are delayed, login to your account for live prices
Login Medicamen Biotech Fundamentals
P/E Ratio
49.41
P/B Ratio
1.97
Div. Yield
0.26
Sector P/E
69.98
Sector P/B
0.95
Sec. Div. Yield
0.57
Medicamen Biotech Fundamentals is currently trading with a P/E Ratio of 49.41, compared to the sector average of 69.98. Its P/B Ratio stands at 1.97, while the sector’s is 0.95. In terms of returns, the stock offers a Dividend Yield of 0.26%, which is than the sector’s 0.57%.
Medicamen Biotech Score Card
Price
Expensive
Growth
Poor
Quality
Poor
Management
Average
On its scorecard, Medicamen Biotech reflects: Price – Expensive, Growth – Poor, Quality – Poor, and Management – Average. Together, these indicators provide a structured view of the company’s fundamentals.
